Alliqua, Inc.
CIK:0001054274|SEC Filings
Condensed Consolidated Statements of Operations (Unaudited) - USD ($) $ in Thousands |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Jun. 30, 2019 |
Jun. 30, 2018 |
Jun. 30, 2019 |
Jun. 30, 2018 |
|
| Operating expenses | ||||
| Research and development | $ 1,895 | $ 583 | $ 3,226 | $ 1,269 |
| General and administrative | 1,454 | 598 | 2,317 | 1,292 |
| Grant reimbursements | (1,104) | (1,198) | ||
| Total operating expenses, net | 2,245 | 1,181 | 4,345 | 2,561 |
| Loss from operations | (2,245) | (1,181) | (4,345) | (2,561) |
| Interest expense, net | (2,373) | (301) | (2,641) | (445) |
| Other income (expense), net | 60 | (94) | 60 | |
| Loss from continuing operations | (4,618) | (1,422) | (7,080) | (2,946) |
| Loss from discontinued operations | (58) | (58) | ||
| Net loss | $ (4,676) | $ (1,422) | $ (7,138) | $ (2,946) |
| Net loss per basic and diluted share: | ||||
| Loss from continuing operations (in dollars per share) | $ (1.17) | $ (2.03) | $ (3.03) | $ (4.20) |
| Loss from discontinued operations (in dollars per share) | (0.01) | (0.02) | ||
| Net loss per basic and diluted share (in dollars per share) | $ (1.18) | $ (2.03) | $ (3.05) | $ (4.20) |
| Weighted-average number of common shares outstanding - basic and diluted (in shares) | 3,956,226 | 701,808 | 2,338,007 | 701,808 |